Description
The abstract mentions multiple therapeutic approaches (senolytics, senomorphics, stem cell therapies) but provides no guidance on their relative efficacy or optimal application in stroke contexts. This represents a critical translational gap for developing targeted anti-senescence stroke therapies.
Gap type: open_question Source paper: Senescence and SASP Are Potential Therapeutic Targets for Ischemic Stroke. (2024, Pharmaceuticals (Basel, Switzerland), PMID:38543098)
Resolution criteria
[“Comparative efficacy study of 3 senolytic regimens (navitoclax, dasatinib+quercetin, fisetin) in aged post-stroke mice (2 months post-MCAO) shows >=30% reduction in p16Ink4a+ cells in brain by flow cytometry”, “Senomorphic (SIRT1 activation) vs senolytic comparison in post-stroke mice shows distinct functional recovery profiles at 90 days”, “Spatial transcriptomics of post-stroke brain identifies 10+ senescence-associated secretory phenotype (SASP) factors driving neuroinflammation”, “Cognitive testing (novel object recognition, Morris water maze) at 60 days post-stroke shows correlation between senescent cell burden and functional deficits”]
Evidence summary
{“resolution_pipeline”: “scidex.atlas.gap_closure_pipeline”, “task_id”: “f4f7b129-0f43-4c84-abd8-20d4e701842d”, “evaluated_at”: “2026-04-28T19:10:17.055054+00:00”, “resolution_summary”: “Resolved by hypothesis h-7957bb2a: Senescence-Induced Lipid Peroxidation Spreading. Supporting evidence includes debate sess_SDA-2026-04-07-gap-pubmed-20260406-041445-7e1dc0b2_task_9aae8fc5.”, “match_counts”: {“hypothesis_matches”: 2, “debate_matches”: 5, “paper_matches”: 0}, “hypothesis_matches”: [{“id”: “h-7957bb2a”, “title”: “Senescence-Induced Lipid Peroxidation Spreading”, “score”: 0.23, “reason”: “25 token overlaps; entity overlap: sasp”, “analysis_id”: “sda-2026-04-01-gap-013”, “target_gene”: “GPX4/SLC7A11”, “target_pathway”: “Cellular senescence / SASP signaling”, “disease”: “neurodegeneration”, “composite_score”: 0.730067, “confidence_score”: 0.4, “status”: “debated”, “pubmed_evidence_ids”: [“34692910”, “39134283”, “40214929”, “40937759”, “41016294”]}, {“id”: “h-d5dea85f”, “title”: “Microglial Senescence Prevention via TREM2/SASP Axis”, “score”: 0.224, “reason”: “18 token overlaps; entity overlap: sasp”, “analysis_id”: “SDA-2026-04-16-gap-pubmed-20260410-150544-e3a2eab9”, “target_gene”: “TREM2”, “target_pathway”: null, “disease”: “neurodegeneration”, “composite_score”: 0.837096, “confidence_score”: 0.48, “status”: “proposed”, “pubmed_evidence_ids”: [“28602351”, “28802038”, “30738892”, “31902528”, “31932797”]}], “debate_matches”: [{“id”: “sess_SDA-2026-04-07-gap-pubmed-20260406-041445-7e1dc0b2_task_9aae8fc5”, “title”: “While the abstract identifies AQP4 as a ‘potential and promising target’ and mentions it could provide ‘new therapeutic alternatives,’ the specific approaches for therapeutic modulation of AQP4 function are not defined. This represents a critical translational gap for moving from mechanistic understanding to clinical intervention.\n\nGap type: open_question\nSource paper: Aquaporin-4 in glymphatic system, and its implication for central nervous system disorders. (2023, Neurobiol Dis, PMID:36796590)”, “score”: 0.475, “reason”: “13 token overlaps; entity overlap: pmid”, “analysis_id”: “SDA-2026-04-07-gap-pubmed-20260406-041445-7e1dc0b2”, “quality_score”: 0.76, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-07-gap-pubmed-20260406-062207-e4ce5cf0_task_9aae8fc5”, “title”: “The abstract mentions that pathological seeds have different characteristics and conformations, but the underlying molecular mechanisms that generate this diversity remain unclear. Understanding these mechanisms is critical for developing targeted therapeutic interventions.\n\nGap type: unexplained_observation\nSource paper: Protein transmission in neurodegenerative disease. (2020, Nat Rev Neurol, PMID:32203399)”, “score”: 0.441, “reason”: “11 token overlaps; entity overlap: pmid”, “analysis_id”: “SDA-2026-04-07-gap-pubmed-20260406-062207-e4ce5cf0”, “quality_score”: 0.65, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-15-gap-pubmed-20260411-090658-7651c1d2_20260416-033018”, “title”: “The abstract shows p53 is a central regulator of C9orf72-mediated neurodegeneration but doesn’t explain how poly(PR) specifically activates p53. Understanding this upstream trigger mechanism is critical for developing targeted therapeutic interventions.\n\nGap type: unexplained_observation\nSource paper: p53 is a central regulator driving neurodegeneration caused by C9orf72 poly(PR). (None, None, PMID:33482083)”, “score”: 0.412, “reason”: “10 token overlaps; entity overlap: pmid”, “analysis_id”: “SDA-2026-04-15-gap-pubmed-20260411-090658-7651c1d2”, “quality_score”: 0.61, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-08-gap-pubmed-20260406-062111-e3e328bf_task_9aae8fc5”, “title”: “The abstract mentions that antibody discovery has improved understanding of myelitis pathophysiology but focuses on a review of uncommon myelopathies where mechanisms remain poorly characterized. Understanding these mechanisms is critical for developing targeted therapies for rare but debilitating conditions.\n\nGap type: unexplained_observation\nSource paper: Uncommon inflammatory/immune-related myelopathies. (2021, J Neuroimmunol, PMID:34715593)”, “score”: 0.393, “reason”: “10 token overlaps; entity overlap: pmid”, “analysis_id”: “SDA-2026-04-08-gap-pubmed-20260406-062111-e3e328bf”, “quality_score”: 0.655, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-13-gap-pubmed-20260410-142329-c1db787b_20260413-202651”, “title”: “The title suggests B cells actively maintain tolerance to AQP4, but the specific molecular mechanisms by which B cells prevent anti-AQP4 autoimmunity are not detailed. Understanding this tolerance mechanism is critical for developing targeted therapies for neuromyelitis optica.\n\nGap type: unexplained_observation\nSource paper: B cells orchestrate tolerance to the neuromyelitis optica autoantigen AQP4. (2024, Nature, PMID:38383779)”, “score”: 0.392, “reason”: “9 token overlaps; entity overlap: pmid”, “analysis_id”: “SDA-2026-04-13-gap-pubmed-20260410-142329-c1db787b”, “quality_score”: 0.79, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}], “paper_matches”: []}